Uterine sarcoma following adjuvant radiotherapy for rectal carcinoma

Authors

  • Patrick J. Marmion MD,

    1. Department of Pathology, Mercy Hospital and Medical Center, and the San Diego Tumor Institute, San Diego
    Current affiliation:
    1. Mercy Hospital and Medical Center, 4077 Fifth Avenue, San Diego, CA 92103
    Search for more papers by this author
  • Paul M. Goldfarb MD,

    Corresponding author
    1. Department of Pathology, Mercy Hospital and Medical Center, and the San Diego Tumor Institute, San Diego
    • San Diego Tumor Institute Medical Group, 108 University Avenue, San Diego, CA 92103
    Search for more papers by this author
  • Tyler P. Youngkin MD

    1. Department of Pathology, Mercy Hospital and Medical Center, and the San Diego Tumor Institute, San Diego
    Current affiliation:
    1. Mercy Hospital and Medical Center, 4077 Fifth Avenue, San Diego, CA 92103
    Search for more papers by this author

Abstract

Since adjuvant radiotherapy for rectosigmoid carcinoma appears to improve prognosis, the importance of delayed side effects such as radiation-induced malignant disease must be considered. The present report describes the first reported case of the development of a uterine carcinosarcoma more than 9 years after preoperative radiotherapy to the midpelvis for rectal carcinoma.

Ancillary